2020
DOI: 10.1016/j.gene.2020.144887
|View full text |Cite
|
Sign up to set email alerts
|

Recipient interleukin 6 gene polymorphism and expression predict HCV recurrence post liver transplantation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 12 publications
(4 citation statements)
references
References 47 publications
0
4
0
Order By: Relevance
“…Infection with hepatitis C virus can lead to a systemic increase in the production of a variety of in ammatory cytokines, especially interleukin-6 (IL6) and tumor necrosis factor-a (TNF-α). Tumor necrosis factor is a key member of the tumor necrosis factor receptor superfamily (TNFSF), which is produced by the activation of macrophages caused by tissue damage [47][48].…”
Section: Discussionmentioning
confidence: 99%
“…Infection with hepatitis C virus can lead to a systemic increase in the production of a variety of in ammatory cytokines, especially interleukin-6 (IL6) and tumor necrosis factor-a (TNF-α). Tumor necrosis factor is a key member of the tumor necrosis factor receptor superfamily (TNFSF), which is produced by the activation of macrophages caused by tissue damage [47][48].…”
Section: Discussionmentioning
confidence: 99%
“… 40 Hepatic inflammation, including the innate immune cell stimulation and cytokine generation, is a master cause for liver injury. 41 , 42 IL-6 secreted into the liver during the initial stages of inflammation induces an enormous number of proteins, 43 including CRP, fibrinogen, haptoglobin, alpha-antitrypsin and serum amyloid A (SAA). On the contrary, IL-6 was reported to lessen albumin, fibronectin, and transferrin generation.…”
Section: Introductionmentioning
confidence: 99%
“…On other point of view, the recipient genotype is more feasible and obtainable before transplantation earlier than the donor genotype. However, many studies correlated only the recipient genotype (for TLR4, IL6, and IL-28B SNPs) with the HCV recurrence [28,41,45,46], and more attention is needed to identify new predictors.…”
Section: Discussionmentioning
confidence: 99%
“…Theoretically, CRS may be used to stratify patients who are eligible for OLT or not better than a liver biopsy. The latter represents a single time point in the extended natural history of chronic infection, while genetic markers are and “life-long.” Also, we have a growing base of evidence linking a variant in the IL6 rs1800795 G allele with HCV recurrence post-LT [ 28 ]. Moreover, we finished a promising study which validated CRS performance in 240 Egyptian HCV-infected patients with different fibrosis grades [ 29 ].…”
Section: Introductionmentioning
confidence: 99%